Item Posts Archive - Page 2 of 1767

Comparing the effectiveness of combined therapy of bortezomib, melphalan, and prednisone with versus without daratumumab in patients with multiple myeloma ineligible for a transplant

Posted by Medivizor on Sep 17, 2023 in Multiple Myeloma | 0 comments

In a nutshell The study evaluated the effectiveness of combined therapy of bortezomib (Velcade), melphalan (Alkeran), and prednisone (Deltasone) with (D-VMP) versus without (VMP) daratumumab (Darzalex) in transplant-ineligible patients newly diagnosed with multiple myeloma (MM). The study concluded that D-VMP was more effective than using...

Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.

Posted by Medivizor on Sep 17, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reported the long-term safety and effectiveness of nivolumab (Opdivo; N) + AVD (doxorubicin, vinblastine, and dacarbazine) chemotherapy combinations in patients with early-stage unfavorable classical Hodgkin lymphoma (cHL). The data showed that the N+AVD combination is safe and highly effective over the long term for these...

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Posted by Medivizor on Sep 17, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa (ABBV-951) for the treatment of motor fluctuations in patients with Parkinson’s disease (PD). The data showed that continuous subcutaneous foslevodopa-foscarbidopa significantly improved motor fluctuations in these patients. Some...

Comparing the effectiveness and safety of 5 injections of OnabotulinumtoxinA versus the standard 20 injections for the treatment of patients with overactive bladder.

Posted by Medivizor on Sep 17, 2023 in Overactive bladder | 0 comments

In a nutshell This study compared the effectiveness and safety of 5 injections of onabotulinumtoxinA (OBTA; Botox) versus the standard 20 injections for the treatment of patients with overactive bladder (OAB). The study found that a reduced technique of 5 injections of OBTA was safe and as effective as the standard technique of 20 injections for the...

Does statin use improve survival outcomes in men with advanced prostate cancer undergoing androgen deprivation therapy?

Posted by Medivizor on Sep 17, 2023 in Prostate cancer | 0 comments

In a nutshell This study evaluated the association between statin (cholesterol-lowering drugs) use and survival outcomes in men with advanced prostate cancer (PC) undergoing androgen deprivation therapy (ADT). The data showed that statin use improved the survival outcomes in these patients. Some background Metastatic prostate cancer (PC) is a form of...

Comparing the effectiveness of combined therapy of bortezomib, melphalan, and prednisone with versus without daratumumab in patients with multiple myeloma ineligible for a transplant

Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Comparing the effectiveness and safety of 5 injections of OnabotulinumtoxinA versus the standard 20 injections for the treatment of patients with overactive bladder.

Does statin use improve survival outcomes in men with advanced prostate cancer undergoing androgen deprivation therapy?

Categories

Recent Posts

Archives

Comparing the effectiveness of combined therapy of bortezomib, melphalan, and prednisone with versus without daratumumab in patients with multiple myeloma ineligible for a transplant

Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Comparing the effectiveness and safety of 5 injections of OnabotulinumtoxinA versus the standard 20 injections for the treatment of patients with overactive bladder.

Does statin use improve survival outcomes in men with advanced prostate cancer undergoing androgen deprivation therapy?

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email